Biotech companies are seeing significant pre-market activity this Friday, hinting at possible breakout opportunities.
By evaluating sentiment and momentum before the bell, premarket analysis becomes a foundational step in any trader's routine.
In the Green - Premarket Gainers
On Friday, the following stocks were trading significantly higher in the premarket session.
1. Replimune Group, Inc. (REPL) - up 69% at $7.922. aTyr Pharma, Inc. (ATYR) - up 15% at $0.563. Basel Medical Group Ltd. (BMGL) - up 10% at $0.644. Artiva Biotherapeutics, Inc. (ARTV) - up 10% at $8.345. Moolec Science SA. (MLEC) - up 10% at $2.426. Citius Oncology, Inc. (CTOR) - up 8% at $0.877. Galectin Therapeutics Inc. (GALT) - up 6% at $2.738. KALA BIO, Inc. (KALA) - up 6% at $2.509. Polaryx Therapeutics, Inc. (PLYX) - up 5% at $3.2010. Keros Therapeutics, Inc. (KROS) - up 5% at $12
In the Red - Premarket Losers
The following stocks were trading lower in the premarket session on Friday.
1. Rocket One Inc. (RKTO) - down 16% at $1.432. SciSparc Ltd. (SPRC) -down 13% at $9.153. Aethlon Medical, Inc. (AEMD) -down 11% at $2.604. Sunshine Biopharma, Inc. (SBFM) -down 8% at $0.295. BioNexus Gene Lab Corp. (BGLC) - down 8% at $2.216. AIM ImmunoTech Inc. (AIM) -down 8% at $0.417. Nuwellis, Inc. (NUWE) -down 7% at $0.788. Jupiter Neurosciences, Inc. (JUNS) -down 7% at $0.279. Indaptus Therapeutics, Inc. (INDP) - down 7% at $1.3510. BioRestorative Therapies, Inc. (BRTX) - down 6% at $0.45
For More Such Biotech Stock News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.